JP2019525903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019525903A5 JP2019525903A5 JP2018566415A JP2018566415A JP2019525903A5 JP 2019525903 A5 JP2019525903 A5 JP 2019525903A5 JP 2018566415 A JP2018566415 A JP 2018566415A JP 2018566415 A JP2018566415 A JP 2018566415A JP 2019525903 A5 JP2019525903 A5 JP 2019525903A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- inhibitor
- c14orf142
- tmem229b
- kif3b
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023107289A JP2023123748A (ja) | 2016-06-14 | 2023-06-29 | 転移性癌の診断及び治療の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2,932,910 | 2016-06-14 | ||
| CA2932910A CA2932910A1 (en) | 2016-06-14 | 2016-06-14 | Methods for diagnosing and treating metastatic cancer |
| PCT/CA2017/050729 WO2017214726A1 (en) | 2016-06-14 | 2017-06-14 | Methods for diagnosing and treating metastatic cancer |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023107289A Division JP2023123748A (ja) | 2016-06-14 | 2023-06-29 | 転移性癌の診断及び治療の方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019525903A JP2019525903A (ja) | 2019-09-12 |
| JP2019525903A5 true JP2019525903A5 (enExample) | 2023-06-02 |
| JP7306829B2 JP7306829B2 (ja) | 2023-07-11 |
Family
ID=60655897
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018566415A Active JP7306829B2 (ja) | 2016-06-14 | 2017-06-14 | 転移性癌の診断及び治療の方法 |
| JP2023107289A Pending JP2023123748A (ja) | 2016-06-14 | 2023-06-29 | 転移性癌の診断及び治療の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023107289A Pending JP2023123748A (ja) | 2016-06-14 | 2023-06-29 | 転移性癌の診断及び治療の方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11236331B2 (enExample) |
| EP (1) | EP3468564A4 (enExample) |
| JP (2) | JP7306829B2 (enExample) |
| CN (1) | CN109562121A (enExample) |
| AU (2) | AU2017285726B2 (enExample) |
| CA (2) | CA2932910A1 (enExample) |
| MX (2) | MX2018015474A (enExample) |
| WO (1) | WO2017214726A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11304988B2 (en) * | 2018-01-24 | 2022-04-19 | Northwestern University | Inhibiting tumor cell migration by inhibition of kinesin light chain 1, variant 1 (KLC1C) |
| US20210251963A1 (en) * | 2018-09-06 | 2021-08-19 | Scandion Oncology A/S | Urea derivatives for use in the treatment of subjects with elevated expression and/or activity of srpk1 |
| CN117187375B (zh) * | 2023-09-12 | 2024-06-18 | 上海谱希和光基因科技有限公司 | Kdelr3生物标志物在诊断高度近视中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US6040166A (en) | 1985-03-28 | 2000-03-21 | Roche Molecular Systems, Inc. | Kits for amplifying and detecting nucleic acid sequences, including a probe |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
| US5116742A (en) | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
| CA1340807C (en) | 1988-02-24 | 1999-11-02 | Lawrence T. Malek | Nucleic acid amplification process |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| DE3938907C2 (de) | 1989-11-24 | 1999-11-04 | Dade Behring Marburg Gmbh | Mittel zum Lagern und Suspendieren von Zellen, insbesondere Erythrozyten |
| FR2814349B1 (fr) | 2000-09-27 | 2002-12-06 | Salomon Sa | Sac a dos |
| JP5435529B2 (ja) * | 2005-09-02 | 2014-03-05 | 東レ株式会社 | 腎ガン診断、腎ガン患者予後予測のための組成物および方法 |
| CN101300348A (zh) * | 2005-09-02 | 2008-11-05 | 东丽株式会社 | 肾癌诊断、肾癌患者预后预测用的组合物及方法 |
| WO2007056604A2 (en) | 2005-11-09 | 2007-05-18 | Irm Llc | Methods and compositions for modulating cell motility and inhibiting tumor metastasis |
| GB0724532D0 (en) * | 2007-12-17 | 2008-01-30 | Nat Univ Ireland | Trail variants for treating cancer |
| US20140342946A1 (en) * | 2011-12-31 | 2014-11-20 | Moni Abraham Kuriakose | Diagnostic tests for predicting prognosis, recurrence, resistance or sensitivity to therapy and metastatic status in cancer |
| US20160025728A1 (en) | 2013-03-15 | 2016-01-28 | Board Of Regents, The University Of Texas System | Brain-specific gene signature of tumor cells |
| JP6663149B2 (ja) * | 2014-07-04 | 2020-03-11 | 国立大学法人高知大学 | 膵がん細胞浸潤転移阻害剤 |
-
2016
- 2016-06-14 CA CA2932910A patent/CA2932910A1/en not_active Abandoned
-
2017
- 2017-06-14 MX MX2018015474A patent/MX2018015474A/es unknown
- 2017-06-14 CA CA3027430A patent/CA3027430A1/en active Pending
- 2017-06-14 US US16/309,800 patent/US11236331B2/en active Active
- 2017-06-14 WO PCT/CA2017/050729 patent/WO2017214726A1/en not_active Ceased
- 2017-06-14 AU AU2017285726A patent/AU2017285726B2/en active Active
- 2017-06-14 JP JP2018566415A patent/JP7306829B2/ja active Active
- 2017-06-14 CN CN201780045853.9A patent/CN109562121A/zh active Pending
- 2017-06-14 EP EP17812358.4A patent/EP3468564A4/en active Pending
-
2018
- 2018-12-13 MX MX2022012073A patent/MX2022012073A/es unknown
-
2021
- 2021-12-22 US US17/558,705 patent/US12421514B2/en active Active
-
2023
- 2023-06-15 AU AU2023203737A patent/AU2023203737B2/en active Active
- 2023-06-29 JP JP2023107289A patent/JP2023123748A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6748687B2 (ja) | オフターゲットを防ぐために変形したｒｎａ干渉を誘導する核酸、遺伝子発現抑制用組成物、遺伝子発現抑制用キット、細胞内ターゲット遺伝子の発現抑制方法、オフターゲット効果を抑制する方法 | |
| Barh et al. | MicroRNA let-7: an emerging next-generation cancer therapeutic | |
| O’HARA et al. | MicroRNAs: key modulators of posttranscriptional gene expression | |
| US8729041B2 (en) | Compositions and methods for treating hepatic neoplasia | |
| US20240076677A1 (en) | TOXIC RNAi ACTIVE SEED SEQUENCES FOR KILLING CANCER CELLS | |
| JP7851986B2 (ja) | プログラム可能なｓｉＲＮＡ及びその使用 | |
| WO2004111190A3 (en) | IN VIVO HIGH THROUGHPUT SELECTION OF EFFECTIVE RNAi PROBES | |
| JP2012135301A5 (enExample) | ||
| WO2003070970A3 (en) | RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) | |
| WO2011056073A3 (en) | Novel compounds for modulating neovascularisation and methods of treatment using these compounds | |
| JP2019525903A5 (enExample) | ||
| Liao et al. | Biomembrane-permeable and ribonuclease-resistant siRNA with enhanced activity | |
| KR20180040107A (ko) | Rna 간섭 유도 핵산 및 이를 포함하는 hpv 감염 유발 암의 치료용 약학 조성물 | |
| US11319541B2 (en) | Anticancer therapeutic intervention | |
| US8907075B2 (en) | Compositions and methods for gene silencing | |
| JP2018520150A5 (enExample) | ||
| US9550989B2 (en) | Rational design of microRNA-siRNA chimeras for multi-functional target suppression | |
| Lee et al. | RNA interference-mediated simultaneous silencing of four genes using cross-shaped RNA | |
| Siomi et al. | A potential link between transgene silencing and poly (A) tails | |
| US20120115928A1 (en) | Mirna and its targets respectively the proteins made based on the targets as a prognostic, diagnostic biomarker and therapeutic agent for cancer | |
| CN103571839B (zh) | 具有转录和转录后双水平基因沉默功能的microRNA的筛选方法 | |
| WO2023196944A3 (en) | Oligonucleotide interference treatments of prostate cancer | |
| CN107630015A (zh) | 一种稳定的dna‑rna双链结构 | |
| Winter et al. | RNA meets disease in paradise | |
| CN101220369A (zh) | 碳纳米管作为siRNA载体及其转染方法 |